Sona Nanotech, Inc.

  • Market Cap: N/A
  • Industry: Specialty Chemicals
  • ISIN: CA83541C1059
CAD
0.50
0.01 (2.04%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Sona Nanotech, Inc. stock-summary
stock-summary
Sona Nanotech, Inc.
Specialty Chemicals
Sona Nanotech Inc. is a nanotechnology life sciences company. The principal business is the development and application of its technology for use in multiplex diagnostic testing platforms. The Company offers a suite of products and services for multiple applications, including custom conjugation, lateral flow test development, lateral flow test production, point of care diagnostics, drug delivery, photo-thermal therapy and cell imaging. The Company’s products include Lateral flow. Its Lateral flow is a technology and a paper-based diagnostic test used to confirm the presence or absence of a target analyte in a sample without the need for specialist lab equipment. Lateral flow tests are used in various sectors, which include animal and veterinary health, food and drink, environmental testing, agricultural testing, and drugs of abuse.
Company Coordinates stock-summary
Company Details
Purdy's Wharf Tower 2, 1969 Upper Water St Suite 2001 HALIFAX NS : B3J 3R7
stock-summary
Tel: 1 902 4821240
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.02%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Daniel Whittaker
Chairman of the Board
Mr. Zephaniah Mbugua
Director
Dr. Andrew Smith
Director
Mr. James Megann
Independent Director
Dr. Michael Gross
Independent Director
Mr. Robert McKay
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - Apr 2025)
Net Profit:
-1 Million
stock-summary
Industry

Specialty Chemicals

stock-summary
Market cap

CAD 73 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.05

stock-summary
Return on Equity

-328.95%

stock-summary
Price to Book

72.59